Data underlying the publication: Radiofrequency ablation for thyroid nodules (RATED study) - analysis of a learning curve and predictors of success
doi: 10.4121/dd66122a-77c2-4f05-a34a-6b5aed8223e0
Context Radiofrequency ablation (RFA) is used as treatment for symptomatic thyroid nodules. However, factors influencing the volume reduction ratio (VRR) at 12 months are not yet fully understood. Objective The primary objective was evaluating the VRR at 12 months after RFA. Secondary objectives were the assessment of a learning curve and factors influencing the VRR at 12 months. Design This is a retrospective Dutch multi-center study. Patients and intervention Patients who underwent RFA for symptomatic thyroid nodules with available ultrasound follow-up were eligible for this study. Main outcome measures Ultrasound based VRR at 12 months and chronologically numbered RFA procedures. All patients’ baseline, ultrasound, treatment, and early follow-up factors were assessed for correlation with VRR at 12 months.
- 2024-09-30 first online, published, posted
2. Rijnstate, Dept. of Internal Medicine, Arnhem, The Netherlands
3. University of Twente, Multi-modality Medical Imaging, TechMed Center, Enschede, The Netherlands
4. Amsterdam UMC, Location Vrije Universiteit Amsterdam, Dept. of Radiology and Nuclear Medicine, Amsterdam,
The Netherlands
5. Amsterdam UMC, Location Vrije Universiteit Amsterdam, Dept. of Endocrinology and Metabolism, Amsterdam,
The Netherlands.
6. Meander Medical Center, Dept. of Internal Medicine, Amersfoort, The Netherlands
7. Ziekenhuisgroep Twente, Dept. of Radiology, Almelo, The Netherlands
8. University of Twente, Physics of Fluids, TechMed Center, Enschede, The Netherlands
9. Humanitas University and Clinical Research Center, Milan, Italy
10. Radboudumc, Dept. of Radiology and Nuclear Medicine, Nijmegen, The Netherlands
DATA
- 20,615 bytesMD5:
6a52589146a1c92b139c138811e3d3a6
Supplementary table S1.docx -
download all files (zip)
20,615 bytes unzipped